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INTRODUCTION: 
Many drugs are delivered orally as it is the most favorable 
route of drug administration. Nevertheless, many potential 
hydrophilic drugs such as protein and peptide drugs 
administrated orally exhibit low oral bioavailability 
mainly due to their low intestinal permeability. For such 
kind of drugs defined as “high solubility low permeability 
class” or a biopharmaceutical classification system [BCS] 
class III drug, gastrointestinal permeation is the rate 
controlling step in the absorption process1. Transport of 
hydrophilic drugs across the intestinal epithelium is 
confined mainly to paracellular pathways. However, the 
limited surface area and the tight junctions present 
between the adjacent cells restrict the transport of the 
drugs and are responsible for the low bioavailability of 
hydrophilic drugs across the paracellular route. The small 
oil globules are absorbed through lymphatic system their 
by bypass portal circulation and hepatic first pass effect. 
Also the drugs which undergo hepatic first pass effect 
have low bioavailability which can be improved by 
absorption and transport through lymphatic system. Many 
approaches such as absorption enhancers2, chemical 
modifications3 and pharmaceutical means were used to 
enhance oral bioavailability of those drugs. Among these 
approaches, water-in-oil-in-water emulsions show great 
potential for enhancing oral bioavailability of BCS class 
III drugs4, 5. 
The majority of orally administered drugs gain access to 
the systemic circulation by direct absorption into the 
portal blood. However, highly lipophilic compounds may 
reach the systemic blood circulation via the intestinal 
lymphatic system. This alternative lymphatic absorption 
pathway from the gastrointestinal tract (GIT) has been 
shown to be a significant contributor to the overall 
bioavailability.  
SDEDDS are poly dispersed systems where the dispersed 
phase contains the droplets of the continuous phase. These 
double emulsions are of two types: W/O/W types multiple 
emulsions and O/W/O types multiple emulsions6. Small 
water droplets are dispersed in bigger oil droplets and 
these oil droplets are again dispersed in continuous 
aqueous phases7, Similarly in O/W/O type multiple 
emulsions, small oil droplets are dispersed in larger 
aqueous droplet and these aqueous droplets are again 
dispersed in continuous oil phase. Their potential 
pharmaceutical applications include uses such as taste 
masking, adjuvant vaccines and an immobilization of 
enzymes, sorbent reservoir of overdose treatments and for 
enhancement of enteral or dermal absorption8. Multiple 
emulsions have been formulated as cosmetics, such as 
skin moisturizer. Prolonged release can also be obtained 
by means of multiple structures. These systems have some 
advantages, such as the protection of the entrapped 
substances and the incorporation of several actives in the 
different compartments. Despite their potential usefulness, 
applications of multiple emulsions have been limited 
because of thermodynamic instability and their complex 
structure9. The basic rationale for the use of W/O/W and 
O/W/O type multiple emulsions as means of prolonged 
delivery of drugs is that the drug contained in the 
innermost phase of forced to partition itself through 
several phases prior to release at the absorption site10. 
Thus the partition and diffusion coefficient of the drug and 
the strength of the middle membrane phase, which is a 
multi molecular layer of oil, water, and emulsifier 
molecules at both the interfaces of multiple emulsion 
system, control the drug release from these systems11. 
Although multiple emulsions are still infrequently used, 
their potential applications are numerous and the 
investigation of these systems is now an active field 
research, especially in such product areas as 
pharmaceutical drug delivery systems, cosmetics and 
foods12.  
Approaches to improve the bioavailability of BCS Class 
III drugs are: 
 Permeation enhancers 
 Prodrug 
 Chemical modification 
 Pharmaceutical means 
 Multiple / Double emulsions 
 
ABSTRACT:  
Self emulsifying drug delivery systems (SEDDS) are well known for its potential to improve the aqueous solubility and oral 
absorption of lipophilic drugs. Self double-emulsifying drug delivery system (SDEDDS) are basically used for drugs having low 
solubility in water, but its potential application for the drugs defined as “high solubility low permeability class” or a  
biopharmaceutical classification system [BCS] class III drug is appreciable, in which gastrointestinal permeation is the rate  
controlling step in the absorption process. The most important factor affecting the oral absorption of a drug, besides dissolution, is 
the permeability of the drug across the gastrointestinal lining. Improving permeability may, therefore, potentially improve the 
bioavailability of a drug. In this review we discuss the preparation, stability, formulation and characterization of SDEDDS. 
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COMPOSITION OF SDEDDS: 
 The self double emulsifying process is depends on 
 Emulsification equipment  
 Nature of the aqueous  phase 
  Nature of the oil phase 
 Volume of dispersed phase  
 Nature and quantity of emulsifying agents 
 Added stabilizing component 
Emulsifying equipment: 
The primary emulsion can be prepared using a laboratory 
mixer or homogenizer to provide a good dispersion of 
droplets within the appropriate continuous phase13,14. The 
secondary emulsification stage must disperse the primary 
emulsion into droplets of suitable size for use in delivery 
vehicles Excessive mixing, especially at high shear, can 
cause the primary emulsion droplets to rupture. Low-
speed, low-shear mixers should be used, or the system can 
be shaken by hand. Ultrasonic homogenizers must be used 
with care for the secondary emulsification step. 
Nature of the aqueous phase: 
The aqueous phase is the dispersed phase in a w/o 
emulsion and a continuous phase in a w/o/w emulsion. 
Internal aqueous phase are often solution of encapsulated 
compound, such as sugar, salt and nutrient15. External 
aqueous phase are solutions of emulsifiers e.g. proteins 
and stabilizers e.g. polysaccharide. The volume fraction of 
the aqueous phase has large effect on stability of double 
emulsion. 
Nature of the oil phase: 
The oil phase to be employed in a pharmaceutical 
emulsion must be nontoxic and it also determines the 
encapsulation efficiency of emulsion. Vegetable oils 
usually have higher viscosity and higher solubility than 
mineral oil. Emulsion made from vegetable oil require  a 
higher energy input and the resulting emulsion is less 
stable to the migration of water in and out of the internal 
aqueous phase. However high hydrophobicity materials 
such as mineral oils or hydrocarbon solvents are 
commonly used as the oil phase in studies of w/o or w/o/w 
emulsion. The various oils of vegetable origin (soybean 
oil, corn oil, sesame, peanut, safflower, etc.) are 
acceptable if purified correctly. Refined hydrocarbons 
such as light liquid paraffin squalene, as well as esters of 
fatty acids (ethyl oleate and isopropyl myristate) have also 
been used in double emulsions16. Oils derived from 
vegetable sources are biodegradable, whereas those based 
on mineral oils are only removed from the body very 
slowly. The order of decreasing stability and percentage 
entrapment has been found to be light liquid paraffin > 
squalene > sesame oil > maize or peanut oil14. 
Volumes of the phases: 
The quantity of water dispersed in the initial w/o emulsion 
[expressed as a phase volume ratio, (w/o/w)] can have an 
influence on both the yield and stability of the final 
emulsion system. 
Nature and quantity of emulsifying agents: 
Two different emulsifier (lipophilic and hydrophilic) are 
required to form a stable emulsion. In general, for a w/o/w 
emulsion the optimal HLB value will be in the range 2-7 
for the primary surfactant and in the range 6-16 for the 
secondary surfactant. The concentration of the emulsifiers 
can also be varied. Too little emulsifier may result in 
unstable system, whereas too much emulsifier may lead to 
toxic effect and can even cause destabilization17. 
Added stabilizing components: 
The stabilizer are added for improve the stability of 
multiple emulsion. These include gelling or viscosity –
increasing agents added to the internal or external aqueous 
phases (e.g.20% gelatin18, methylcellulose and similar 
thickening agents ,as well as complexing agent that will 
lead to liquid crystalline phase at the O/W interface (e.g. 
cetyl alcohol) and gelling agent or the oil phase (e.g. 
aluminium  monostearate)13. 
PREPARATION OF SDEDDS: 
SDEDDS emulsions are best prepared by re-
emulsification of primary emulsion. The following are the 
method of multiple emulsions: 
1. Two Steps Emulsification (Double Emulsification) 
2. Phase Inversion Technique (One Step Technique) 
3. Membrane Emulsification Technique 
1.  Two Steps Emulsification (Double Emulsification)
 
19, 20
: 
Two steps emulsification methods involve re-
emulsification of primary W/O or O/W emulsion using a 
suitable emulsifier agent. The first step involves, obtaining 
an ordinary W/O or O/W primary emulsion wherein an 
appropriate emulsifier system is utilized. In the second 
step, the freshly prepared W/O or O/W primary emulsion 
is re-emulsified with an excess of aqueous phase or oil 
phase. The finally prepared emulsion could be W/O /W or 
O/W/O respectively. 
2. Phase Inversion Technique (One Step Technique)
 21, 
22
: 
An increase in volume concentration of dispersed phase 
may cause an increase in the phase volume ratio, which 
subsequently leads the formation of multiple emulsions. 
The method typically involves the addition of an aqueous 
phase contains the hydrophilic emulsifier [Tween 80/ 
sodium dodecyl sulphate (SDS) or Cetyl trimethyl 
ammonium salt CTAB)] to an oil phase consisted of liquid 
paraffin and containing lipophilic emulsifier (Span80). A 
well-defined volume of oil phase is placed in a vessel 
of pin mixer. An aqueous solution of emulsifier is then 
introduced successively to the oil phase in the vessel at a 
rate of 5 ml/min, while the pin mixer rotates steadily at 88 
rpm at room temperature. When volume fraction of the 
aqueous solution of hydrophilic emulsifier exceeds 0.7, 
the continuous oil phase is substituted by the aqueous 
phase containing a number of the vesicular globules 
among the simple oil droplets, leading to phase inversion 
and formation of W/O/W multiple emulsion. 
3. Membrane Emulsification Technique
23
: 
In this method, a W/O emulsion (a dispersed phase) is 
extruded into an external aqueous phase (a continuous 
phase) with a constant pressure through a Porous Glass 
Membrane, which should have controlled and 
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homogenous pores. The particle size of the resulting 
emulsion can be controlled with proper selection of 
Porous Glass Membrane as the droplet size depends upon 
the pore size of the droplet size depends upon the pore 
size of the membrane. The relation between membrane 
pore size and particle size of W/O/W emulsion exhibits 
good correlation as described by the following equation: 
Y= 5.03 X + 0.19 
Where X is the pore size and Y is the mean particle size of 
the multiple prepared using membrane emulsifier 
technique. 
CHARACTERIZATION OF SDEDDS 
FORMULATIONS: 
1. Viscosity analysis of SDEDDS formulations  
The rheological measurements of the formulations cam be 
performed with a programmable rheometer, (Brookfield 
viscometer) operating with cone plate geometry (cone 
diameter 60mm, angle 1◦, and gap 0.058 mm).  Samples 
transferred to the instrument and allowed to equilibrate to 
25±1 ◦C for 10 min prior to the measurement. The 
apparent viscosity can be measured over a shear rate range 
of 0.1–300 s−1. Viscosities (mPa s) of each formulation 
were measured at different shear rates; the mean constant 
shear viscosity may be determined from the data obtained 
at 300 s−1. Six replicate analyses may be presented as       
means ± SD. 
2.  pH determination 
The pH value of the freshly prepared emulsions and the 
emulsions kept at different conditions can be determined 
by a digital pH-meter. pH measurements were repeated for 
multiple emulsions after 1, 3, 7, 14, 21 and 28 days of 
preparation, may be used for adjustments in formulation 
parameter24. 
3. Microscopic tests 
Multiple emulsions have to be analyzed under the 
microscope to confirm the multiple characters. A drop of 
multiple emulsions have to be placed on the glass slide, 
diluted with water and covered by a glass cover. A drop of 
immersion oil placed on the cover slide and to be 
observed under the microscope. 
4. Entrapment efficiency  
The amount of drug entrapped is the amount of total drug 
minus the amount of free drug separated in the lower 
phase of the emulsion by centrifugation. The entrapped 
efficiency of the drug is defined as,  
Efficiency of drug entrapped (%) = [(Td – Fd) / Td] Χ 100  
Where, Td = Total drug added, Fd = free drug present in 
the separated oil or aqueous phase25, 26. 
5. Release of drug from SDEDDS formulations in vitro 
Release profiles from formulation filled in capsules have 
to be performed using the USP30 rotating paddle 
apparatus with 900 ml of simulated gastric fluid (SGF, pH 
1.2) without pepsin as the medium at 37±0.5 ◦C. The 
speed of the paddle was adjusted to 75 rpm. Samples (5 
ml) are to be withdrawn and replaced with fresh media 
after 5, 15, 30, 60, 120, 240, 360 and 480 min. Samples 
are filtered using a 0.45micrometer filter and analyzed 
using an HPLC assay. Three replicate analyses are carried 
out for each formulation, and data presented as means ± 
SD.  
6. Electrical conductivity tests 
Conductivity tests are performed for the multiple 
emulsions immediately after preparation and for the 
samples kept at different conditions by using digital 
conductivity-meter. Conductivity tests are repeated for the 
multiple emulsions after 1, 3, 7, 14, 21 and 28 days of 
preparation27, 28. 
7. Turbidity Measurement: 
This is to identify efficient self-emulsification by 
establishing whether the dispersion reaches Equilibrium 
rapidly and in a reproducible time. Nepheloturbidimetric 
evaluation is done to monitor the growth of 
emulsification. Fixed quantity of Self emulsifying system 
is added to fixed quantity of suitable medium (0.1N 
hydrochloric acid) under continuous stirring (50 rpm) on 
magnetic plate at ambient temperature, and the increase in 
turbidity is measured using a turbidimeter29. 
8. Emulsion droplet size analysis: 
The droplet size distribution of double emulsions will 
influence the rheology, stability, color and test. These are 
generally measured by dynamic light scattering using a 
Malvern Particle Size Analyzers equipped with a He–Ne 
laser. SDEDDS are mixed with distilled water (200 ml) 
and stirred at mild agitation (75 rpm) in a magnetic stirrer 
for 5min at room temperature, forming the double 
emulsions. The particle size distribution of the double 
emulsions is determined after presentation. The refractive 
index of dispersed phase and continuous phase were 
calculated respectively, and the absorbance values of the 
emulsion droplets are calculated. The results are reported 
as the volume average diameter30. 
9. Stability studies: 
Stability tests can be performed at different storage 
conditions for both primary and multiple emulsions. The 
tests are performed on samples kept at 2 ± 0.1 ⁰C (in 
refrigerator), 25 ± 0.1oC 60%RH (relative humidity), 40 ± 
0.1 ⁰C at 75% (RH) (in stability chamber) and 50⁰c in 
oven. 
10. In-vivo method: 
Male Wister rats are used and acclimatized for 7 days and 
fed the solid feed for 6 weeks. Weights of the rats serving 
as recipients of the W/O/W emulsions were 200–250 g. 
Before feeding the sample solutions, the rats are fasted 
overnight for 17 h. After being anesthetized with ether, 
blood samples are collected from the coccygeal vein 5 min 
before the administration using 23–27 gauge needles and 
used as the reference blood-sugar level at 0 min. The 
sample solutions are fed at 50 IU/kg-weight using feeding 
tubes. Purified water as a control solution, which 
contained insulin at the same concentration as the other 
emulsions, is also fed. The blood samples are collected at 
15, 30, 45, 60, 120, 180, and 240 min from the coccygeal 
vein under temporary ether anesthesia. The blood 
concentrations in the samples can be measured by 
spectrophotometry or HPLC determination31. 
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PHARMACEUTICAL APPLICATIONS OF 
MULTIPLE EMULSIONS:  
1. They can mask the bitter taste and order of drug, e.g. 
chlorpromazine32. 
2. Multiple emulsions are used in food33. 
3. They can be used to prolong the release of drug thereby 
providing sustained release action34, 35.  
4. Essential nutrients like carbohydrates, fats and vitamins 
can all be emulsified and can be administered to bed ridden 
patient as sterile intravenous injection. 
5. Emulsion provides protection to drugs which are 
susceptible to oxidation or hydrolysis36, 37. 
6. Intravenous emulsions of contrast media have been 
developing to assist in diagnosis. 
7. Increase in dosing interval. 
8. Hydrophilic as well as hydrophobic drug can be entrapped.  
CONCLUSION: 
From last 100 years, the only route available for the delivery of 
certain protein, peptide and anticancer drug is of injectable 
origin. The presentation of such highly soluble drugs via oral 
route has great commercial importance regarding the patient 
compliance, stability of product, the ease of formulation and 
manufacturing consideration. The present study will be an 
attempt to describe the role of oral route for systemic delivery of 
such highly water soluble (BCS Class-III) drugs. The 
investigation will provide the delivery of such drugs by utilizing 
the lymphatic system and also provide the means for delivery of 
highly water soluble, poorly permeable life saving drugs used in 
the disease like cancer, diabetes, vaccine etc. The evaluation of 
such products will definitely beneficial for the future delivery of 
such drugs. 
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